ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Immunoglobulins (Ig)"

  • 2019 American Transplant Congress

    Extracellular Vesicles (EV) Mediate Antibody-Independent Tubular Senescence via Cyclin-Dependent Kinase Inhibitors p21/p16 in Antibody-Mediated Rejection (AMR)

    C. Divella1, A. Stasi1, R. Franzin1, F. Sallustio2, C. Curci1, G. Merlotti3, M. Quaglia3, L. Gesualdo1, V. Cantaluppi1, G. Castellano1

    1Emergency and Organ Transplantation, University of Bari, Bari, Italy, 2Emergency and Organ Transplantation / Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy, 3Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy

    *Purpose: Recent data suggest a strong correlation between kidney injury and the occurrence of accelerated senescence process, known as “Inflammaging”. However, the role of TEC…
  • 2019 American Transplant Congress

    Alloreactive B Cells in Transplant Tolerant Recipients Cannot Differentiate into Antibody-Secreting Cells but Can Suppress Donor-Specific IgG Production By Naïve B Cells

    S. H. Khiew1, J. Chen1, D. Jain1, Q. Wang1, D. Yin1, M. Alegre2, A. S. Chong1

    1Department of Surgery, Section of Transplant, University of Chicago, Chicago, IL, 2Department of Medicine, University of Chicago, Chicago, IL

    *Purpose: Donor specific transplantation tolerance has long been the goal of clinical transplantation. Clinical observations suggest that donor-specific antibodies (DSA) are a major cause of…
  • 2019 American Transplant Congress

    B Cell Immunophenotypes in Transplantation

    M. Cascalho1, M. de Mattos-Barbosa2, E. A. Farkash3, J. L. Platt2

    1University of Michigan, Ann Arbor, MI, 2Surgery, University of Michigan, Ann Arbor, MI, 3Pathology, University of Michigan, Ann Arbor, MI

    *Purpose: B cells and B cell responses have been associated with favorable outcomes of transplantation in some setting and unfavorable outcomes in others. For example,…
  • 2018 American Transplant Congress

    APRIL/BLyS Blockade Improves Depletion of Antibody Secreting B Cells Compared to BLyS Blockade Alone in Sensitized Murine Kidney Transplant Model

    N. Bath,1 X. Ding,1 N. Wilson,2 B. Verhoven,1 A. Sukhwal,1 L. Coons,1 S. Panzer,2 A. Djamali,2 R. Redfield.1

    1Surgery, University of Wisconsin, Madison, WI; 2Medicine, University of Wisconsin, Madison, WI.

    Introduction: Antibody mediated rejection (AMR) remains a significant problem in highly sensitized individuals undergoing kidney transplantation. APRIL (A Proliferation Inducing Ligand) and BLyS (B Lymphocyte…
  • 2018 American Transplant Congress

    Identification of Human SIRPa Diversity That Could Regulate Innate Allorecognition

    A. Friday,1 H. Dai,1 A. Williams,1 M. Oberbarnscheidt,1 J. Danska,2 F. Lakkis.1

    1Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA; 2Immunology and Medical Biophysics, University of Toronto, Toronto, ON, Canada.

    Innate allorecognition is a process by which myeloid cells, such as monocytes, distinguish syngeneic from allogeneic cells. Monocytes that recognize donor cells as non-self differentiate…
  • 2018 American Transplant Congress

    The Complexity of HLA-DQ

    D. Pinelli, A. Tambur.

    Northwestern University, Chicago.

    Historically, HLA-DQ antigens and antibodies (Ab) were difficult to classify due to the lack of serological typing reagents. However, with the advent of molecular typing…
  • 2018 American Transplant Congress

    Comparison of C1Q Binding and Flow Cytometric Crossmatch Results Provides an Accurate Evaluation of Hypersensitive Kidney Transplant Patients

    E. Eksioğlu-Demiralp,1 A. Türkmen,2 B. Yelken,2 S. Görçin,2 O. Elbasi,1 F. Yalçin,3 B. Koçak,2 C. Karatas,4 M. Tuncer,4 M. Altinel.3

    1Tissue Typing and Immunology Laboratory, Memorial Health Group, Istanbul, Turkey; 2Sisli Hospital Transplantation Unit, Memorial Health Group, Istanbul, Turkey; 3Hizmet Hospital Transplantation Unit, Memorial Health Group, Istanbul, Turkey; 4Atasehir Hospital Transplantation Unit, Memorial Health Group, Istanbul, Turkey.

    Measurement of C1q binding to Donor specific antibodies (DSA) gives transplantation chance to hypersensitive patients having non-binding high amount of anti-HLA antibodies. In our series…
  • 2018 American Transplant Congress

    Temporal Variability of IgG Subclasses

    D. Pinelli, M. Gopalakrishnan, A. Joong, P. Thrush, A. Tambur.

    Northwestern University, Chicago; Lurie Children's Hospital, Chicago.

    The temporal model of IgG subclass switching supports sequential IgG conversion; however, the diversity of previously stimulated B cells is known to shape responses in…
  • 2018 American Transplant Congress

    The Results of Plasmapheresis and Anti-CD20 Based Desensitization without Intravenous Immunoglobulin in Positive Crossmatch Kidney Transplants

    H. Kwon, Y. KIm, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.

    Asan Medical Center, Seoul, Korea.

    This study examined the mid-term clinical outcomes in positive crossmatch kidney transplants (XMKT) for patients who received desensitization with plasmapheresis (PP) and anti-CD20 based regimens…
  • 2018 American Transplant Congress

    Early Adjunctive Treatment with Human Cytomegaly Virus (CMV) Immunoglobulin Increased CMV-Free Survival after Heart Transplantation

    M. Barten,1 C. Neumaier,1 A. Bernhardt,1 M. Rybczynski,2 R. Plaetke,3 H. Reichenspurner.1

    1Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany; 2General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany; 3Institute of Medical Biometry and Epidemiology, University Hospital Eppendorf Hamburg, Hamburg, Germany.

    Purpose: There is still an ongoing discussion whether a prophylactic or a preemptive therapy against cytomegalovirus (CMV) is superior to reduce the incidence of CMV…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences